Drug Shortage Report for XALATAN
Report ID | 171016 |
Drug Identification Number | 02231493 |
Brand name | XALATAN |
Common or Proper name | XALATAN |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LATANOPROST |
Strength(s) | 50MCG |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 2.5ML |
ATC code | S01EE |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-12-14 |
Actual start date | 2022-12-14 |
Estimated end date | 2023-03-22 |
Actual end date | 2023-03-23 |
Shortage status | Resolved |
Updated date | 2023-05-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-05-05 | French | Compare |
v9 | 2023-05-05 | English | Compare |
v8 | 2023-03-20 | French | Compare |
v7 | 2023-03-20 | English | Compare |
v6 | 2023-01-17 | French | Compare |
v5 | 2023-01-17 | English | Compare |
v4 | 2022-12-22 | English | Compare |
v3 | 2022-10-04 | French | Compare |
v2 | 2022-10-04 | English | Compare |
v1 | 2022-10-04 | English | Compare |
Showing 1 to 10 of 10